Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
New York, N.Y., Aug. 27, 2025 (GLOBE NEWSWIRE) -- NANO Nuclear Energy Inc. (NASDAQ: NNE) (“NANO Nuclear” or “the Company”), a leading advanced nuclear energy and technology company focused on...
-
LOS ANGELES, Aug. 07, 2025 (GLOBE NEWSWIRE) -- The 2025 Pet Innovation Awards today announced that the Dogginstix Beef Collagen UFO from Dogginstix, a Revnaq brand, has been selected as “Dog...
-
Glen Ellyn, Ill., April 22, 2021 (GLOBE NEWSWIRE) -- Join College of DuPage for STEMCON, a free event celebrating science, technology, engineering and math Friday, April 23, to Sunday, April 25. ...
-
NEW HAVEN, Conn., Jan. 15, 2019 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announced that Makati Medical Center (MakatiMed) in Manila, the Philippines,...
-
NEW HAVEN, Conn., Jan. 10, 2019 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), today announced that it has been approved by the United States Department of...
-
NEW HAVEN, Conn., Nov. 27, 2018 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announced that its ICE COLD-PCR™ (ICP) technology has been selected for a...
-
Precipio ICE COLD-PCR™ reagents will be sold with PerkinElmer DNA/RNA extraction and isolation products NEW HAVEN, Conn., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company...
-
Glen Ellyn, Ill., June 26, 2018 (GLOBE NEWSWIRE) -- College of DuPage student Young Hak Ahn has dedicated much of his life to exploring the world and people around him. Ahn earned his master’s...
-
NEW HAVEN, Conn., June 14, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO), today reminded its shareholders to vote on proposals 1-6 in accordance with the...
-
NEW HAVEN, Conn., June 06, 2018 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), today announced the award of US patent No. 9,957,556 entitled FULL COLD-PCR...